Travere Therapeutics, Inc. (TVTX): Weighted Average Diluted Shares
89.21M
Year ended 2025-12-31
+11.8%
3-year compound annual growth
+13.4%
5-year compound annual growth
+9.0%
10-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 89.21M | +13.1% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | 78.89M | +6.2% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | 74.27M | +16.5% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | 63.76M | +6.6% | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | 59.83M | +25.9% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | 47.54M | +12.3% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | 42.34M | +4.7% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | 40.43M | +4.3% | 2019-02-26, From 2018-01-01 |
| 2017-12-31 | 38.77M | +1.3% | 2019-02-26, From 2017-01-01 |
| 2016-12-31 | 38.29M | +1.9% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | 37.58M | n/c | 2018-07-06, From 2015-01-01 |
| 2014-12-31 | 25.06M | +76.4% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | 14.21M | n/a | 2016-02-26, From 2013-01-01 |